Golden Biotechnology Corporation (TPEX:4132)
Taiwan
· Delayed Price · Currency is TWD 13.05
-0.90 (-6.45%)
Mar 9, 2026, 1:58 PM CST
Golden Biotechnology Revenue
Golden Biotechnology had revenue of 26.62M TWD in the half year ending June 30, 2025, a decrease of -7.87%. This brings the company's revenue in the last twelve months to 44.58M, down -22.46% year-over-year. In the year 2024, Golden Biotechnology had annual revenue of 40.92M, down -35.49%.
Revenue (ttm)
44.58M
Revenue Growth
-22.46%
P/S Ratio
48.21
Revenue / Employee
365.43K
Employees
116
Market Cap
2.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.92M | -22.51M | -35.49% |
| Dec 31, 2023 | 63.43M | -154.40M | -70.88% |
| Dec 31, 2022 | 217.83M | 136.06M | 166.39% |
| Dec 31, 2021 | 81.77M | -7.06M | -7.94% |
| Dec 31, 2020 | 88.83M | 5.53M | 6.64% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Johnson Chemical Pharmaceutical Works | 567.06M |
| Allied Biotech | 821.81M |
| TSH Biopharm Corporation | 1.34B |
| PhytoHealth | 134.58M |
| Maywufa Company | 1.58B |
| GeneFerm Biotechnology | 677.10M |
| Tien Liang BioTech | 467.02M |
| InnoPharmax | 55.77M |